Transcend Capital Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.27M | Sell |
|
|||||
|
2025
Q2 | $1.28M | Sell |
|
|||||
|
2025
Q1 | $3.89M | Sell |
|
|||||
|
2024
Q4 | $4.76M | Sell |
|
|||||
|
2024
Q3 | $6.08M | Buy |
|
|||||
|
2024
Q2 | $6.08M | Buy |
|
|||||
|
2024
Q1 | $1.46M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $212K | Sell |
|
|||||
|
2023
Q1 | $224K | Sell |
|
|||||
|
2022
Q4 | $301K | Sell |
|
|||||
|
2022
Q3 | $267K | Sell |
|
|||||
|
2022
Q2 | $373K | Buy |
|
|||||
|
2022
Q1 | $361K | Buy |
|
|||||
|
2021
Q4 | $309K | Buy |
|
|||||
|
2021
Q3 | $282K | Sell |
|
|||||
|
2021
Q2 | $271K | Sell |
|
|||||
|
2021
Q1 | $346K | Buy |
|
|||||
|
2020
Q4 | $262K | Buy |
|